Tenascin-C predicts IVIG non-responsiveness and coronary artery lesions in kawasaki disease in a Chinese cohort

被引:2
作者
Li, Yujie [1 ]
Xu, Ziqing [1 ]
Wu, Lin [1 ]
Liang, Xuecun [1 ]
Zhao, Lu [1 ]
Liu, Fang [1 ]
Wang, Feng [1 ]
机构
[1] Fudan Univ, Dept Cardiol, Childrens Hosp, Shanghai, Peoples R China
来源
FRONTIERS IN PEDIATRICS | 2022年 / 10卷
关键词
tenascin-C; IVIG non-responsiveness; coronary artery lesions; children; Kawasaki disease; INTRAVENOUS IMMUNOGLOBULIN UNRESPONSIVENESS; RISK-FACTORS; CHILDREN; RESISTANCE; COMPLICATIONS; EXPRESSION; PROGNOSIS; ANEURYSMS; THERAPY;
D O I
10.3389/fped.2022.979026
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
ObjectivesTo assess the predictive value of tenascin-C (TN-C) for intravenous immunoglobulin (IVIG) non-responsiveness and coronary artery lesions (CALs) development at the acute stage of Kawasaki disease, and to build novel scoring systems for identifying IVIG non-responsiveness and CALs. MethodsA total of 261 patients in acute-stage Kawasaki disease were included. Serum samples before IVIG initiation were collected and TN-C expression levels were measured using an enzyme-linked immunosorbent assay. In addition to TN-C, another fifteen clinical and laboratory parameters collected before treatment were compared between IVIG responsive and non-responsive groups, and between groups with and without CALs. Multiple logistic regression analyses were performed to construct new scoring systems for the prediction of IVIG non-responsiveness and CALs development. ResultsIVIG non-responsive group (n = 51) had significantly higher TN-C level compared to IVIG responsive group (n = 210) (15.44 vs. 12.38 IU/L, P < 0.001). A novel scoring system composed of TN-C, total bilirubin, serum sodium and albumin was established to predict IVIG non-responsiveness. Patients with a total score >= 2 points were classified as high-risk cases. With the sensitivity of 78.4% and specificity of 73.8%, the efficiency of our scoring system for predicting IVIG non-responsiveness was comparable to the Kobayashi system. Consistently, the group developing CALs at the acute stage (n = 42) had significantly higher TN-C level compared to the group without CALs (n = 219) (19.76 vs. 12.10 IU/L, P < 0.001). A new scoring system showed that patients with elevated TN-C, platelet count >= 450 x 10(9)/L, and delayed initial infusion of IVIG had a higher risk of developing CALs. Individuals with a total score >= 3 points were classified as high-risk cases. The sensitivity and specificity of the novel simple system for predicting CALs development were 83.3% and 74.0%, respectively, yielding a better efficiency than the Harada score. ConclusionElevated TN-C appeared to be an independent risk factor for both IVIG non-responsiveness and CALs in Chinese children with KD. Our scoring systems containing TN-C is simple and efficient in the early identification of high-risk KD cases that could benefit from more individualized medications.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Corticosteroids Added to Initial Intravenous Immunoglobulin Treatment for the Prevention of Coronary Artery Abnormalities in High-Risk Patients With Kawasaki Disease
    Ae, Ryusuke
    Abrams, Joseph Y.
    Maddox, Ryan A.
    Schonberger, Lawrence B.
    Nakamura, Yosikazu
    Kuwabara, Masanari
    Makino, Nobuko
    Matsubara, Yuri
    Kosami, Koki
    Sasahara, Teppei
    Belay, Ermias D.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (17):
  • [2] Tenascin C may regulate the recruitment of smooth muscle cells during coronary artery development
    Ando, Katsumi
    Takahashi, Makiko
    Yamagishi, Toshiyuki
    Miyagawa-Tomita, Sachiko
    Imanaka-Yoshida, Kyoko
    Yoshida, Toshimichi
    Nakajima, Yuji
    [J]. DIFFERENTIATION, 2011, 81 (05) : 299 - 306
  • [3] Circulating tenascin-C levels in patients with idiopathic dilated cardiomyopathy
    Aso, N
    Tamura, A
    Nasu, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (11) : 1468 - 1470
  • [4] Analysis of risk factors and prospective evaluation of cardiovascular complications of Kawasaki disease in children: a single centre study
    Berdej-Szczot, Elzbieta
    Firek-Pedras, Malgorzata
    Szydlowski, Leslaw
    Krzystolik-Ladzinska, Joanna
    Klimek, Katarzyna
    Malecka-Tendera, Ewa
    [J]. KARDIOLOGIA POLSKA, 2013, 71 (12) : 1279 - 1286
  • [5] Edraki MR, 2020, ARCH IRAN MED, V23, P31
  • [6] Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease
    Egami, Kimiyasu
    Muta, Hiromi
    Ishii, Masahiro
    Suda, Kenji
    Sugahara, Yoko
    Iemura, Motofumi
    Matsuishi, Toyojiro
    [J]. JOURNAL OF PEDIATRICS, 2006, 149 (02) : 237 - 240
  • [7] Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort
    Fabi, Marianna
    Andreozzi, Laura
    Corinaldesi, Elena
    Bodnar, Tetyana
    Lami, Francesca
    Cicero, Cristina
    Tchana, Bertrand
    Landini, Chiara
    Sprocati, Monica
    Bigucci, Barbara
    Balsamo, Claudia
    Valin, Paola Sogno
    Di Fazzio, Giorgia
    Iughetti, Lorenzo
    Valletta, Enrico
    Marchetti, Federico
    Donti, Andrea
    Lanari, Marcello
    [J]. EUROPEAN JOURNAL OF PEDIATRICS, 2019, 178 (03) : 315 - 322
  • [8] Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
    Galeotti, Caroline
    Kaveri, Srini V.
    Cimaz, Rolando
    Kone-Paut, Isabelle
    Bayry, Jagadeesh
    [J]. DRUG DISCOVERY TODAY, 2016, 21 (11) : 1850 - 1857
  • [9] The role of tenascin C in cardiovascular disease
    Golledge, Jonathan
    Clancy, Paula
    Maguire, Jane
    Lincz, Lisa
    Koblar, Simon
    [J]. CARDIOVASCULAR RESEARCH, 2011, 92 (01) : 19 - 28
  • [10] When Children With Kawasaki Disease Grow Up Myocardial and Vascular Complications in Adulthood
    Gordon, John B.
    Kahn, Andrew M.
    Burns, Jane C.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (21) : 1911 - 1920